Christopher Peetz Insider Trading $MIRM Mirum Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Peetz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Peetz. Christopher Peetz is Chief Financial Officer in Tobira Therapeutics, Inc. ($TBRA) and Director in ALPINE IMMUNE SCIENCES, INC. ($ALPN) and President and CEO in Mirum Pharmaceuticals, Inc. ($MIRM).
Christopher Peetz in Mirum Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Peetz: President and CEO
Holdings: 2,824 shares
Latest Transaction: May 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Christopher Peetz in Mirum Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, MIRM, TBRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Grant | A | 14.62 | 1,453 | 21,243 | 2,824 | 1.4 K to 2.8 K (+105.98 %) |
| Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Option Exercise | A | 19.19 | 175,000 | 3,358,250 | 175,000 | |
| Dec 28 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 18.60 | 2,000 | 37,200 | 201,570 | 199.6 K to 201.6 K (+1.00 %) |
| Dec 28 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 18.76 | 3,000 | 56,280 | 199,570 | 196.6 K to 199.6 K (+1.53 %) |
| Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Grant | A | 15.27 | 1,371 | 20,930 | 1,371 | 0 to 1.4 K |
| Jan 14 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Option Exercise | A | 19.24 | 170,000 | 3,270,800 | 170,000 | |
| Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 11.35 | 2,320 | 26,332 | 196,570 | 194.3 K to 196.6 K (+1.19 %) |
| Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 11.35 | 2,320 | 26,332 | 196,570 | 194.3 K to 196.6 K (+1.19 %) |
| Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.90 | 2,000 | 21,800 | 194,250 | 192.3 K to 194.3 K (+1.04 %) |
| Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.90 | 2,000 | 21,800 | 194,250 | 192.3 K to 194.3 K (+1.04 %) |
| Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.91 | 4,750 | 51,806 | 192,250 | 187.5 K to 192.3 K (+2.53 %) |
| Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.91 | 4,750 | 51,806 | 192,250 | 187.5 K to 192.3 K (+2.53 %) |
Page: 1